The Fanconi Anemia Research Fund (FARF) is the world leader in advancing research for better treatments and a cure for Fanconi anemia (FA). Founded in 1989 by parents Lynn and David Frohnmayer, FARF’s mission is to find better treatments and a cure for Fanconi anemia and to provide education and support services to affected families worldwide. To that end, as of 2021, FARF has supported more than 265 grants to nearly 200 investigators worldwide. Thanks to generous and dedicated donors, FARF has funded over $26 million in research grants. The research that FARF funds has improved stem cell transplants and goes on to benefit those in the general population who may battle cancer. That’s why the Fanconi Anemia Research Fund is a model that demonstrates how a small group of dedicated families can speed the pace of scientific progress and bring real benefits to patients with an otherwise fatal disorder. FARF-funded research has a ripple effect and goes on to inform new researchers and projects. Each idea or concept builds on the others, taking them closer and closer to a cure. For more information, visit: https://www.fanconi.org.
Disclaimer: The information contained in this page is provided by the partnering patient organization for informational purposes only. The 40 Percent Inc. does not warrant its completeness or accuracy, and it should not be construed as an endorsement by The 40 Percent Inc. or relied upon as a basis for your support for the partnering patient organization. The information is subject to change without notice.